Targeting Mitochondria 2021 Speakers

Introduction Note Volkmar Weissig, President of the World Mitochondria Society, Midwestern University, USA	Optimization of Energy Homeostasis in old Age by SIRT6 Haim Cohen, Bar-Ilan University, Israel
Big Change from Small Player - Mitochondria Alter Body Metabolism and Gene Expression Scott Ballinger, University of Alabama at Birmingham, USA	A Potential Mitochondrial Link Between Life Stress and the Reversibility of Hair Greying in Humans Martin Picard, Columbia University Vagelos College of Physicians and Surgeons, USA
A Session Dedicated to Nuclear-Mitochondrial Interactions and Their Effect on Longevity and Health: Introduction Miria Ricchetti, Team Stability of Nuclear and Mitochondrial DNA, Institut Pasteur, France	Mitochondrial Transplantation Therapy, the Recent Advances and Perspective James McCully, the Harvard Medical School Department of Cardiac Surgery Boston Children’s Hospital, USA
Regulation of Physiological Mitophagy Thomas G. McWilliams, University of Helsinki, Finland	Deciphering Strategic Interactions between Mitochondrial and Nuclear Genome José Antonio Enríquez from Centro Nacional de Investigaciones Cardiovasculares Carlos III, Spain
Circulating Mitochondrial DNA as an Early Indicator of Severe Lung Disease Andrew E. Gelman, Washington University School of Medicine, USA	Mitochondrial DNA in Cancer: The Overlooked Oncogenome Payam A. Gammage, CRUK Beatson Institute, United Kingdom
Mitochondrial Arginase-2 is Essential for IL-10 Metabolic Reprogramming of Inflammatory Macrophages Claire McCoy, Royal College of Surgeons in Ireland, Ireland	Glucose Metabolism Control of T Cell Immunity Ming Li, Immunology Program, Memorial Sloan Kettering Cancer Center, USA
Exercise-Induced, Mitochondrial-Mediated Cell Death in Arrhythmogenic Cardiomyopathy Stephen Chelko, Florida State University, USA	Patient-Specific Brain Organoids for Modeling Mitochondrial Diseases Alessandro Prigione, Heinrich Heine University (HHU), Germany
Nuclear Sensing of Breaks in Mitochondrial DNA Enhances Immune Surveillance Agnel Sfeir, Memorial Sloan Kettering Cancer Center, USA	A Mitochondria-Targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients Paulo J. Oliveira, University of Coimbra, Portugal
The Bioenergetics Consequences of Winter Cold in Small Birds Andreas Nord, Lund University, Sweden	Cardiorespiratory Fitness and Mitochondrial Health as Modulators of COVID-19 Johannes Burtscher, University of Lausanne, Suisse
Mechanism of Membrane-Tethered Mitochondrial Protein Synthesis Antoni Barrientos, University of Miami Miller School of Medicine, USA	Extracellular Mitochondria for Therapy and Diagnosis in Stroke Kazuhide Hayakawa, Harvard Medical School / Massachusetts General Hospital, USA
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: Advances and Perspective Cristina Rodríguez-Varela, Medical Research Institute Hospital La Fe, Spain	Age-Related Mitochondrial Dysfunction as a Key Factor in COVID-19 Disease Guillermo López-Lluch, Universidad Pablo de Olavide-CSIC, Spain
Impact of Mitochondrial Dynamics on Stem Cell Function: Insights from Physiology, Diseases and Aging Mireille Khacho, Faculty of Medicine, University of Ottawa, Canada	Introduction Remarks: Past, Present and Future Egbert Mik, University Medical Center Rotterdam, The Netherlands
Dysregulation of Mitochondria-Lysosome Contacts by GBA1 Dysfunction in Dopaminergic Neuronal Models of Parkinson’s Disease Dimitri Krainc, the Northwestern University Feinberg School of Medicine, USA	MitoE10, MitoQ10 and decylTPP Lower Mitochondrial Supercomplex Levels and Stimulate Glycolysis in Primary Human Skin Fibroblasts Werner Koopman, Department of Biochemistry, Radboud Institute for Molecular Life Sciences, The Netherlands
The One-Carbon Pool Controls Mitochondrial Energy Metabolism via Complex I and Iron-Sulfur Clusters Anna Wredenberg,Max Planck Institute Biology of Ageing–Karolinska Institutet Laboratory, Sweden